Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Safe, accurate methods permitting simultaneous and/or repeated measurement of red blood cell (RBC) survival (RCS) are important to investigate pathophysiology and therapy of anemia. Methods using chromium 51 (51 Cr)‐labeled RBCs are unacceptable for infants, children, and pregnant women. We report RCS measured in vivo using RBCs labeled with several densities of biotin (BioRBCs). STUDY DESIGN AND METHODS: Aliquots of autologous RBCs from eight healthy adult subjects were labeled separately at four discrete biotin densities, mixed, and infused. The proportion of each population of BioRBCs circulating was determined serially by flow cytometry over 20 weeks. For each population, RCS was assessed by the following: 1) posttransfusion BioRBC recovery at 24 hours (PTR 24); 2) time to decrease to 50% of the enrichment at 24 hours (T 50); and 3) mean potential lifespan (MPL). RESULTS: Among the four BioRBC densities, no significant differences in PTR 24 were observed. T 50 and MPL were similar for the two lowest BioRBC densities. In contrast, the two highest BioRBC densities demonstrated progressively decreased T 50 and MPL. CONCLUSIONS: RBCs labeled at four biotin densities can be used to independently and accurately measure PTR 24 and two lowest biotin densities can accurately quantitate long‐term RCS. This method provides a tool for investigating anemia in infants, fetuses, and pregnant women with the following advantages over the standard 51 Cr method: 1) study subjects are not exposed to radiation; 2) small blood volumes (e.g., 20 µL) are required; and 3) multiple independent RCS measurements can be made simultaneously in the same individual.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk
Zhang, D.-L., Wu, J., Shah, B. N., Greutélaers, K. C., Ghosh, M. C., Ollivierre, H., Su, X.-Z., Thuma, P. E., Bedu-Addo, G., Mockenhaupt, F. P., et al. (2018) · Science · doi:10.1126/science.aal2022 · Cited by 150
Jaspers, Y. R. J., Ferdinandusse, S., Dijkstra, I. M. E., Barendsen, R. W., van Lenthe, H., Kulik, W., Engelen, M., Goorden, S. M. I., Vaz, F. M., & Kemp, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00690 · Cited by 69
Rao, S., Zhang, J., Lin, J., Wan, J., & Chen, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247373 · Cited by 4
“Based on the standard marker method, the range of the RBCLS in healthy individuals is 70–140 days [13,14,15].”
Method
Metadata
- Authors
- Mock, D. M., Matthews, N. I., Zhu, S., Strauss, R. G., Schmidt, R. L., Nalbant, D., Cress, G. A., & Widness, J. A.
- Venue
- Transfusion
- Publisher
- Wiley
- Published
- 2010-11-09
- Volume
- 51
- Issue
- 5
- Pages
- 1047-1057
- ISSN
- 0041-1132 (ISSN-L)
- 1537-2995
- OpenAlex
- W1594338155
- Cited by
- 105
- References
- 0
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. https://app.cochat.ai/papers/10.1111/j.1537-2995.2010.02926.x
- The paper
- Mock, D. M., Matthews, N. I., Zhu, S., Strauss, R. G., Schmidt, R. L., Nalbant, D., Cress, G. A., & Widness, J. A. (2011). Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. Transfusion. https://doi.org/10.1111/j.1537-2995.2010.02926.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.